K V Pharmaceutical Co. Class A (NYSE:KV-A)

CAPS Rating: 2 out of 5

Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.

Recs

3
Player Avatar kkconway (99.05) Submitted: 6/1/2011 11:18:43 AM : Outperform Start Price: $3.44 KV-A Score: -60.53

The Parliament of Whores and Pond-Scum Procurers in the Capitol Building (...and don't even get me started on the Democrats!) can't screw up everything. Look for a recovery when the Congress finds bigger fish to burn with their wanton magnifying glass.

Report this Post 1 Comment
Member Avatar SterlingPacific (45.27) Submitted: 8/10/2011 12:18:27 PM
Recs: 0

Nicely put lol

Featured Broker Partners


Advertisement